Northwestern Mutual Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.23M | Sell |
43,416
-747
| -2% | -$141K | ﹤0.01% | 686 |
|
|
2026
Q1 | $8.71M | Buy |
44,163
+1,059
| +2% | +$204K | 0.01% | 638 |
|
|
2025
Q4 | $7.92M | Buy |
43,104
+1,410
| +3% | +$247K | 0.01% | 632 |
|
|
2025
Q3 | $6.4M | Buy |
41,694
+880
| +2% | +$133K | ﹤0.01% | 658 |
|
|
2025
Q2 | $5.7M | Sell |
40,814
-941
| -2% | -$132K | ﹤0.01% | 647 |
|
|
2025
Q1 | $6.14M | Sell |
41,755
-1,319
| -3% | -$191K | 0.01% | 599 |
|
|
2024
Q4 | $5.64M | Sell |
43,074
-5,120
| -11% | -$717K | ﹤0.01% | 583 |
|
|
2024
Q3 | $7.51M | Buy |
48,194
+5,112
| +12% | +$825K | 0.01% | 516 |
|
|
2024
Q2 | $6.72M | Buy |
43,082
+869
| +2% | +$131K | 0.01% | 518 |
|
|
2024
Q1 | $5.72M | Buy |
42,213
+2,475
| +6% | +$328K | 0.01% | 530 |
|
|
2023
Q4 | $5.35M | Buy |
39,738
+1,875
| +5% | +$244K | 0.01% | 525 |
|
|
2023
Q3 | $5.13M | Sell |
37,863
-6,920
| -15% | -$945K | 0.01% | 496 |
|
|
2023
Q2 | $6.41M | Buy |
44,783
+13,048
| +41% | +$1.92M | 0.01% | 459 |
|
|
2023
Q1 | $4.41M | Buy |
31,735
+3,194
| +11% | +$430K | 0.01% | 509 |
|
|
2022
Q4 | $3.87M | Buy |
28,541
+1,694
| +6% | +$212K | 0.01% | 522 |
|
|
2022
Q3 | $2.94M | Buy |
26,847
+2,047
| +8% | +$260K | 0.01% | 523 |
|
|
2022
Q2 | $3.28M | Buy |
24,800
+1,154
| +5% | +$151K | 0.01% | 512 |
|
|
2022
Q1 | $3.14M | Sell |
23,646
-1,277
| -5% | -$153K | 0.01% | 533 |
|
|
2021
Q4 | $2.9M | Buy |
24,923
+1,591
| +7% | +$187K | ﹤0.01% | 522 |
|
|
2021
Q3 | $2.8M | Buy |
23,332
+3,200
| +16% | +$373K | 0.01% | 496 |
|
|
2021
Q2 | $2.41M | Buy |
20,132
+3,872
| +24% | +$425K | ﹤0.01% | 523 |
|
|
2021
Q1 | $1.62M | Sell |
16,260
-4,909
| -23% | -$493K | ﹤0.01% | 565 |
|
|
2020
Q4 | $2.12M | Buy |
21,169
+7,493
| +55% | +$794K | ﹤0.01% | 461 |
|
|
2020
Q3 | $1.5M | Buy |
13,676
+1,286
| +10% | +$143K | ﹤0.01% | 487 |
|
|
2020
Q2 | $1.31M | Buy |
12,390
+1,875
| +18% | +$194K | ﹤0.01% | 480 |
|
|
2020
Q1 | $939K | Buy |
10,515
+79
| +0.8% | +$7.44K | ﹤0.01% | 490 |
|
|
2019
Q4 | $1.04M | Sell |
10,436
-175
| -2% | -$16.5K | ﹤0.01% | 510 |
|
|
2019
Q3 | $946K | Sell |
10,611
-600
| -5% | -$52K | ﹤0.01% | 498 |
|
|
2019
Q2 | $926K | Sell |
11,211
-401
| -3% | -$31.4K | ﹤0.01% | 484 |
|
|
2019
Q1 | $939K | Sell |
11,612
-499
| -4% | -$39.3K | ﹤0.01% | 466 |
|
|
2018
Q4 | $920K | Sell |
12,111
-445
| -4% | -$34.7K | ﹤0.01% | 445 |
|
|
2018
Q3 | $994K | Buy |
12,556
+796
| +7% | +$60.2K | 0.01% | 434 |
|
|
2018
Q2 | $825K | Buy |
11,760
+413
| +4% | +$29.7K | ﹤0.01% | 451 |
|
|
2018
Q1 | $793K | Buy |
11,347
+224
| +2% | +$15.5K | ﹤0.01% | 439 |
|
|
2017
Q4 | $772K | Buy |
11,123
+361
| +3% | +$24.3K | ﹤0.01% | 424 |
|
|
2017
Q3 | $729K | Buy |
10,762
+306
| +3% | +$19.3K | 0.01% | 409 |
|
|
2017
Q2 | $713K | Buy |
10,456
+678
| +7% | +$44.3K | 0.01% | 410 |
|
|
2017
Q1 | $609K | Sell |
9,778
-681
| -7% | -$39.6K | 0.01% | 415 |
|
|
2016
Q4 | $572K | Buy |
10,459
+1,862
| +22% | +$106K | 0.01% | 420 |
|
|
2016
Q3 | $566K | Buy |
8,597
+585
| +7% | +$38.2K | 0.01% | 407 |
|
|
2016
Q2 | $484K | Sell |
8,012
-199
| -2% | -$11.6K | 0.01% | 408 |
|
|
2016
Q1 | $462K | Buy |
8,211
+540
| +7% | +$32.4K | 0.01% | 410 |
|
|
2015
Q4 | $521K | Buy |
7,671
+580
| +8% | +$38K | 0.01% | 345 |
|
|
2015
Q3 | $451K | Buy |
7,091
+20
| +0.3% | +$1.32K | 0.01% | 349 |
|
|
2015
Q2 | $451K | Buy |
7,071
+297
| +4% | +$20.3K | 0.01% | 337 |
|
|
2015
Q1 | $464K | Buy |
6,774
+537
| +9% | +$37.3K | 0.01% | 328 |
|
|
2014
Q4 | $439K | Sell |
6,237
-478
| -7% | -$34.2K | 0.01% | 311 |
|
|
2014
Q3 | $480K | Buy |
6,715
+1,111
| +20% | +$81.3K | 0.02% | 296 |
|
|
2014
Q2 | $416K | Sell |
5,604
-949
| -14% | -$68.6K | 0.02% | 288 |
|
|
2014
Q1 | $425K | Buy |
6,553
+555
| +9% | +$35.8K | 0.02% | 283 |
|
|
2013
Q4 | $356K | Buy |
5,998
+1,215
| +25% | +$66K | 0.02% | 305 |
|
|
2013
Q3 | $248K | Buy |
4,783
+100
| +2% | +$5.02K | 0.01% | 327 |
|
|
2013
Q2 | $222K | Buy |
+4,683
| New | +$238K | 0.01% | 327 |
|
Other funds holding AZN
EP
IA
Northwestern Mutual Wealth Management's AZN Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its AstraZeneca (AZN) stake by 1.7% in Q2 2026, selling an estimated $141K and leaving 43,416 shares worth $8.23M. The position accounts for ﹤0.01% of the portfolio, ranked #686.
Northwestern Mutual Wealth Management first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.71M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Northwestern Mutual Wealth Management held 43,416 shares of AstraZeneca worth $8.23M as of Q2 2026.
- Northwestern Mutual Wealth Management sold 747 AstraZeneca shares in Q2 2026, an estimated $141K.
- AstraZeneca made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #686 holding.
- Northwestern Mutual Wealth Management first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Northwestern Mutual Wealth Management's AstraZeneca position peaked at $8.71M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.